“[￦￦￦닷 YEOTOP3.COM ] ◐지적인◑신금호휴게텔↖신금호립카페ⅰ신금호스파➯신금호마사지ゅ신금호풀싸롱❠신금호키스방✓신금호출장”的搜索结果，显示 241-250 项，共有 12159 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being done to: 1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or ...

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the overall rate of response of brain metastases in subjects with central nervous system (CNS) metastases due to ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

8. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem ...